Frank Takkinen
Stock Analyst at Lake Street
(0.47)
# 4,054
Out of 4,429 analysts
677
Total ratings
37.8%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintained: Buy | n/a | $17.77 | - | 48 | Jun 17, 2026 | |
| NSPR InspireMD | Reiterated: Buy | $4 | $0.71 | +463.38% | 15 | Jun 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $21.19 | +112.36% | 35 | Jun 9, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 | $4.08 | +96.08% | 20 | May 29, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $20 | $15.63 | +27.96% | 48 | May 29, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2.5 | $1.60 | +56.25% | 18 | May 27, 2026 | |
| DXR Daxor | Reiterated: Buy | $23 | $9.75 | +135.90% | 5 | May 26, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 | $13.88 | +44.09% | 11 | May 22, 2026 | |
| ADGM Adagio Medical Holdings | Reiterated: Buy | $4 | $0.68 | +488.24% | 7 | May 21, 2026 | |
| RCEL AVITA Medical | Upgraded: Buy | $3.5 → $6 | $4.01 | +49.63% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.06 | +371.70% | 30 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $12.83 | +63.68% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.88 | +112.77% | 38 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $22.02 | +45.32% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.801 | +149.69% | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.95 | +182.83% | 43 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.73 | +74.52% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $15.30 | +226.80% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.64 | +20.48% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.90 | +105.13% | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $93.95 | +43.69% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.30 | +208.88% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $44.84 | +11.51% | 13 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.28 | +127.27% | 25 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.67 | +172.48% | 6 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $92.20 | +30.15% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $1.5 | $0.0145 | +10,244.83% | 38 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $9.78 | +53.37% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.15 | +97.53% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.634 | +846.37% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $42.61 | +252.03% | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $4.11 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.81 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.16 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.64 → $19.81 | $9.60 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $12 | $0.12075 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $2.95 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $4.25 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.66 | $0.295 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0003 | n/a | 3 | Mar 31, 2022 |
ClearPoint Neuro
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $17.77
Upside: -
InspireMD
Jun 11, 2026
Reiterated: Buy
Price Target: $4
Current: $0.71
Upside: +463.38%
Artivion
Jun 9, 2026
Reiterated: Buy
Price Target: $45
Current: $21.19
Upside: +112.36%
TriSalus Life Sciences
May 29, 2026
Reiterated: Buy
Price Target: $8
Current: $4.08
Upside: +96.08%
NeuroPace
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $15.63
Upside: +27.96%
Hyperfine
May 27, 2026
Reiterated: Buy
Price Target: $2.5
Current: $1.60
Upside: +56.25%
Daxor
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $9.75
Upside: +135.90%
Beta Bionics
May 22, 2026
Reiterated: Buy
Price Target: $20
Current: $13.88
Upside: +44.09%
Adagio Medical Holdings
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.68
Upside: +488.24%
AVITA Medical
May 15, 2026
Upgraded: Buy
Price Target: $3.5 → $6
Current: $4.01
Upside: +49.63%
May 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
May 15, 2026
Reiterated: Buy
Price Target: $21
Current: $12.83
Upside: +63.68%
May 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.88
Upside: +112.77%
May 13, 2026
Reiterated: Buy
Price Target: $32
Current: $22.02
Upside: +45.32%
May 13, 2026
Reiterated: Buy
Price Target: $2
Current: $0.801
Upside: +149.69%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $4.95
Upside: +182.83%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $5.73
Upside: +74.52%
May 8, 2026
Reiterated: Buy
Price Target: $50
Current: $15.30
Upside: +226.80%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $6.64
Upside: +20.48%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $3.90
Upside: +105.13%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $93.95
Upside: +43.69%
Apr 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.30
Upside: +208.88%
Apr 28, 2026
Reiterated: Buy
Price Target: $50
Current: $44.84
Upside: +11.51%
Mar 30, 2026
Reiterated: Buy
Price Target: $12
Current: $5.28
Upside: +127.27%
Feb 26, 2026
Reiterated: Buy
Price Target: $10
Current: $3.67
Upside: +172.48%
Feb 11, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $92.20
Upside: +30.15%
Feb 10, 2026
Maintained: Buy
Price Target: $3 → $1.5
Current: $0.0145
Upside: +10,244.83%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $9.78
Upside: +53.37%
Jan 7, 2026
Reiterated: Buy
Price Target: $24
Current: $12.15
Upside: +97.53%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.634
Upside: +846.37%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $42.61
Upside: +252.03%
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $4.11
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.81
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $5.16
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.64 → $19.81
Current: $9.60
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Maintained: Buy
Price Target: $4 → $12
Current: $0.12075
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $1
Current: $2.95
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $14 → $10
Current: $4.25
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.66
Current: $0.295
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0003
Upside: n/a